Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Rupesh Kotecha MD

Rupesh R. Kotecha MD

Radiation Oncologist, Chief of Radiosurgery, and Director of CNS Metastasis Program, Miami Cancer Institute, Baptist Health South Florida; Associate Professor, FIU Herbert Wertheim College of Medicine, Miami, Florida; Adjunct Faculty at Memorial Sloan Kettering, New York, New York

Rupesh Kotecha, MD, is a board-certified radiation oncologist and Chief of Radiosurgery in the Department of Radiation Oncology and Director of the Central Nervous System (CNS) Metastasis program at Miami Cancer Institute. He is also an Adjunct Faculty at Memorial Sloan Kettering at New York. He has specialized training and experience in utilizing the latest techniques in radiation therapy for both cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiotherapy, including CyberKnife, LINAC-based, and GammaKnife radiosurgery, and stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR). He also specializes in advanced radiation therapy treatment techniques, including re-irradiation, proton beam radiotherapy, and MR-guided radiation therapy. During medical school, Dr. Kotecha was inducted into the Alpha Omega Alpha Honor Medical Society, an organization that recognizes excellence in scholarship and the profession of medicine. He has been an invited speaker at numerous national and international symposiums, and has published multiple book chapters and over 75 articles in peer-reviewed journals, including the Journal of Clinical Oncology, International Journal of Radiation Oncology Biology Physics, Cancer, and Practical Radiation Oncology. His research bandwidth spans investigator initiated trials to multi-center trials to national cooperative group clinical protocols. Dr. Kotecha serves as the CNS co-chair for the Proton Collaborative Group , coordinates the NCI Glioblastoma Clinical Working Group, and is a course director for the annual Miami Brain Symposium. He is an editorial contributor and advisory board member on the topic of brain cancer for Practice Update, an online resource for healthcare providers throughout the United States and around the world.

Specialty: Radiation Oncology

Procedures Performed:

  • 3-D conformal radiotherapy
  • Brachytherapy
  • External beam radiotherapy
  • Gamma Knife radiosurgery
  • Cyberknife radiosurgery
  • Image-guided radiation therapy
  • Intensity modulated radiation therapy
  • Stereotactic body radiotherapy
  • Stereotactic ablative radiotherapy
  • Re-irradiation
  • Spatially fractionated radiotherapy
  • MR-guided radiotherapy
  • Proton beam radiotherapy
  • Cardiac radiosurgery

Education, Fellowship, & Training

Medical School – Michigan State University College of Human Medicine, East Lansing, Mich.

Residency – Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio


Honoraria from Accuray Inc., Elekta AB, ViewRay Inc., Novocure Inc., Elsevier Inc., and Brainlab and institutional research funding from Medtronic Inc., Blue Earth Diagnostics Ltd., Novocure Inc., GT Medical Technologies, AstraZeneca, Exelixis, ViewRay Inc., and Brainlab.